EUVIMEDEUVIMED entdecken
Crossref

Serum Circulating Free Dna of Syncytin-1 As A Novel Molecular Marker for Early Diagnosis of Non-Small-Cell Lung Cancer

Xuewei Zhuang, Jingrong Qian, Xiyan Xia, Yuanling Wang, Hongchun Wang, Liping Jing, Yanli Zhang, Yong Zhang iD

Biomarkers in Medicine · 2022

DOI: 10.2217/bmm-2022-0499 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomarkers in Medicine, 2022. Verfasst von Xuewei Zhuang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Laboratory, Shandong Provincial Third Hospital, Shandong University, Jinan, Shandong, 250031, China. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Cell-Free Nucleic Acids. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 32 Literaturangaben. Gefördert von: Shandong Key Research and Development Program, Shandong Provincial Natural Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Liquid biopsy has been receiving attention as an emerging detection technology in the clinical application of non-small-cell lung cancer (NSCLC).

Methods

We quantified serum circulating free DNA (cfDNA) of syncytin-1 in 126 patients and 106 controls, analyzed the correlation of level with pathological parameters and explored diagnostic utility.

Results

The cfDNA of syncytin-1 levels in NSCLC patients were higher than healthy controls (p < 0.0001). These levels were associated with smoking history (p = 0.0393). The area under the curve of cfDNA of syncytin-1 was 0.802, and combination of cfDNA of syncytin-1/cytokeratin 19 fragment antigen 21-1/carcinoembryonic antigen markers improved diagnostic efficiency.

Conclusion

The cfDNA of syncytin-1 was detected in NSCLC patients and can be used as a novel molecular marker for early diagnosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Non-Small-Cell LungLung NeoplasmsCell-Free Nucleic AcidsHumansBiomarkers, TumorEarly Detection of CancerDNAPregnancy ProteinsGene Products, env

Stichwörter der Autor:innen

circulating free DNAearly diagnosisliquid biopsymolecular markernon-small-cell lung cancersmoking historysyncytin-1

Substanzen

Biomarkers, TumorCell-Free Nucleic AcidsDNAsyncytinPregnancy ProteinsGene Products, env

Autor:innen und Institutionen

  • Department of Clinical Laboratory, Shandong Provincial Third Hospital, Shandong University, Jinan, Shandong, 250031, China.
  • Department of Microbial Immune, Jinan Vocational College of Nursing, Jinan, Shandong, 250102, China.
  • Department of Nursing, Shandong Provincial Third Hospital, Shandong University, Jinan, Shandong, 250031, China.
  • Department of Clinical Laboratory, Shandong University Qilu Hospital, Jinan, Shandong, 250012, China.
  • Department of Hepatobiliary Surgery, Shandong Provincial Third Hospital, Shandong University, Jinan, Shandong, 250031, China.

ORCID-Profile: Yong Zhang

Förderung

  • Shandong Key Research and Development Program
  • Shandong Provincial Natural Science Foundation

Zitieren

APA

Zhuang, X., Qian, J., Xia, X., Wang, Y., Wang, H., Jing, L., Zhang, Y., & Zhang, Y. (2022). Serum Circulating Free Dna of Syncytin-1 As A Novel Molecular Marker for Early Diagnosis of Non-Small-Cell Lung Cancer. Biomarkers in Medicine. https://doi.org/10.2217/bmm-2022-0499

Vancouver

Zhuang X, Qian J, Xia X, Wang Y, Wang H, Jing L, et al. Serum Circulating Free Dna of Syncytin-1 As A Novel Molecular Marker for Early Diagnosis of Non-Small-Cell Lung Cancer. Biomarkers in Medicine. 2022. doi:10.2217/bmm-2022-0499

BibTeX
@article{Zhuang2022,
  author = {Zhuang, Xuewei and Qian, Jingrong and Xia, Xiyan and Wang, Yuanling and Wang, Hongchun and Jing, Liping and Zhang, Yanli and Zhang, Yong},
  title = {Serum Circulating Free Dna of Syncytin-1 As A Novel Molecular Marker for Early Diagnosis of Non-Small-Cell Lung Cancer},
  journal = {Biomarkers in Medicine},
  year = {2022},
  doi = {10.2217/bmm-2022-0499}
}
Kostenlos starten →